{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:08:20Z","timestamp":1782990500693,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Abnormalities in cerebrospinal fluid (CSF)-amyloid-beta (A\u03b2)42, CSF-A\u03b240, CSF-A\u03b238, CSF-soluble amyloid precursor proteins \u03b1 and \u03b2, CSF-total-tau, CSF-phosphorylated-tau, CSF-neurofilament light protein (NF-L), CSF-neurogranin, plasma-A\u03b242, plasma-A\u03b240, plasma-total-tau, plasma-NF-L and, serum-S100B during affective episodes may reflect brain changes that could impact cognitive function in patients with bipolar disorder (BD). The study aimed to investigate the association between these biomarkers indicative of Alzheimer\u2019s disease and those reflecting neurodegeneration alongside their impact on cognitive function in patients with BD and healthy control individuals (HC). The primary hypothesis was that GL and VL would increase with increasing levels of CSF-A\u03b242 based on data from T0 and T3 in BD and HC jointly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a prospective, longitudinal case\u2013control study euthymic patients with BD (N\u2009=\u200985) and HC (N\u2009=\u200944) were evaluated with clinical assessment and neuropsychological testing at baseline (T0) and during euthymia after a year (T3). Patients\u2019 affective states were recorded weekly as euthymic, subthreshold level, major depression, or (hypo)mania. If an episode occurred during follow-up, the patient was also assessed in post-episode euthymia. Cognitive performance was measured as a global cognitive score (GL) for four cognitive domains including verbal learning and memory (VL).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Estimated in a linear mixed model GL increased with 0.001 for each increase of 1\u00a0pg\/ml of CSF-A\u03b242 (97.5%, CI 0.00043\u20130.0018, adjusted-p\u2009=\u20090.0005) while VL increased by 0.00089 (97.5%, CI 0.00015\u20130.0018, adjusted-p\u2009=\u20090.045) in BD and HC jointly. The association was weak, however stronger in patients with BD compared to HC. Associations between other biomarkers including CSF-neurogranin, and cognitive domains were overall weak, and none remained significant after adjustment for multiple testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Limitations<\/jats:title>\n                <jats:p>Modest sample size. A complete data set regarding both CSF-AB-42 and cognitive test scores was obtained from merely 61 patients with BD and 38 HC individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CSF-A\u03b242 may be associated with cognitive dysfunction in patients with BD and HC individuals. The association appeared to be stronger in BD but with overlapping confidence intervals. Hence it remains uncertain whether the association is a general phenomenon or driven by BD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40345-023-00324-5","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T14:02:38Z","timestamp":1705413758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case\u2013control study of patients with bipolar disorder and healthy control individuals"],"prefix":"10.1186","volume":"12","author":[{"given":"Ulla","family":"Knorr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Willkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Miskowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"324_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1017\/S0033291707001675","volume":"38","author":"B Arts","year":"2008","unstructured":"Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38:771\u201385.","journal-title":"Psychol Med"},{"key":"324_CR2","first-page":"1","volume":"326","author":"P Bech","year":"1986","unstructured":"Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1\u201337.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"324_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279\u201384.","journal-title":"Behav Brain Res"},{"key":"324_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2017.12.057","volume":"229","author":"E Bora","year":"2018","unstructured":"Bora E. Neurocognitive features in clinical subgroups of bipolar disorder: a meta-analysis. J Affect Disord. 2018;229:125\u201334.","journal-title":"J Affect Disord"},{"key":"324_CR5","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1017\/S0033291717001490","volume":"47","author":"E Bora","year":"2017","unstructured":"Bora E, Ozerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med. 2017;47:2753\u201366.","journal-title":"Psychol Med"},{"key":"324_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0028-3932(67)90015-2","volume":"5","author":"JG Borkowski","year":"1967","unstructured":"Borkowski JG, Benton AL, Spreen O. Words fluency and brain damage. Neuropsychologia. 1967;5:135\u201340.","journal-title":"Neuropsychologia"},{"issue":"Pt 4","key":"324_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.2044-8260.1987.tb01366.x","volume":"26","author":"JR Crawford","year":"1987","unstructured":"Crawford JR, Besson JA, Parker DM, Sutherland KM, Keen PL. Estimation of premorbid intellectual status in depression. Br J Clin Psychol. 1987;26(Pt 4):313\u20134.","journal-title":"Br J Clin Psychol"},{"key":"324_CR8","first-page":"41","volume":"17","author":"B Cullen","year":"2019","unstructured":"Cullen B, Smith DJ, Deary IJ, Pell JP, Keyes KM, Evans JJ. Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort. Br J Psychiatry. 2019;17:41.","journal-title":"Br J Psychiatry"},{"key":"324_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1192\/bjp.bp.111.101931","volume":"202","author":"J da Silva","year":"2013","unstructured":"da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013;202:177\u201386.","journal-title":"Br J Psychiatry"},{"key":"324_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/9781119513469","volume-title":"Applied longitudinal analysis","author":"GM Fitzmaurice","year":"2011","unstructured":"Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd ed. USA: Wiley; 2011.","edition":"2"},{"key":"324_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100102","volume":"6","author":"J Futtrup","year":"2020","unstructured":"Futtrup J, Margolinsky R, Benros ME, Moos T, Routhe LJ, Rungby J, Krogh J. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case\u2013control studies. Brain Behav Immun Health. 2020;6: 100102.","journal-title":"Brain Behav Immun Health"},{"key":"324_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jad.2016.08.018","volume":"205","author":"JH Jensen","year":"2016","unstructured":"Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: associations with functional abilities. J Affect Disord. 2016;205:378\u201386.","journal-title":"J Affect Disord"},{"key":"324_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eurpsy.2018.11.008","volume":"56","author":"E Jimenez-Lopez","year":"2019","unstructured":"Jimenez-Lopez E, Sanchez-Morla EM, Lopez-Villarreal A, Aparicio AI, Martinez-Vizcaino V, Vieta E, Rodriguez-Jimenez R, Santos JL. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia, a five-year follow-up. Eur Psychiatry. 2019;56:60\u20138.","journal-title":"Eur Psychiatry"},{"key":"324_CR14","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/jnnp.2003.031773","volume":"75","author":"LV Kessing","year":"2004","unstructured":"Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry. 2004;75:1662\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"324_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/acps.12667","volume":"135","author":"LV Kessing","year":"2017","unstructured":"Kessing LV, Andersen PK. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135:51\u201364.","journal-title":"Acta Psychiatr Scand"},{"key":"324_CR16","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1017\/S0033291719001867","volume":"50","author":"HL Kjaerstad","year":"2019","unstructured":"Kjaerstad HL, Mistarz N, Coello K, Stanislaus S, Melbye SA, Harmer CJ, Vinberg M, Miskowiak K, Kessing LV. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives. Psychol Med. 2019;50:1808\u201319.","journal-title":"Psychol Med"},{"key":"324_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41398-019-0664-6","volume":"9","author":"U Knorr","year":"2019","unstructured":"Knorr U, Simonsen AH, Roos P, Weimann A, Henriksen T, Christensen EM, Vinberg M, Mikkelsen RL, Kirkegaard T, Jensen RN, Akhoj M, Forman J, Poulsen HE, Hasselbalch SG, Kessing LV. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case\u2013control study. Transl Psychiatry. 2019;9:325.","journal-title":"Transl Psychiatry"},{"key":"324_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jad.2020.09.055","volume":"278","author":"U Knorr","year":"2020","unstructured":"Knorr U, Miskowiak K, Akh\u00f8j M, Vinberg M, Forman J, Kessing LV. The impact of the trajectory of bipolar disorder on global cognitive function: a one-year clinical prospective case\u2013control study. J Affect Disord. 2020;278:189\u201398.","journal-title":"J Affect Disord"},{"key":"324_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jad.2021.10.074","volume":"297","author":"U Knorr","year":"2022","unstructured":"Knorr U, Simonsen AH, Jensen CS, Zetterberg H, Blennow K, Akh\u00f8j M, Forman J, Hasselbalch SG, Kessing LV. Alzheimer\u2019s disease related biomarkers in bipolar disorder\u2014a longitudinal one-year case\u2013control study. J Affect Disord. 2022;297:623\u201333.","journal-title":"J Affect Disord"},{"key":"324_CR20","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1177\/0271678X20982388","volume":"41","author":"TM Kylkilahti","year":"2021","unstructured":"Kylkilahti TM, Berends E, Ramos M, Shanbhag NC, T\u00f6ger J, Markenroth Bloch K, Lundgaard I. Achieving brain clearance and preventing neurodegenerative diseases\u2014a glymphatic perspective. J Cereb Blood Flow Metab. 2021;41:2137\u201349.","journal-title":"J Cereb Blood Flow Metab"},{"key":"324_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","volume":"15","author":"A Lleo","year":"2019","unstructured":"Lleo A, Alcolea D, Martinez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimon J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer\u2019s disease continuum in the BIOMARKAPD study. Alzheimer\u2019s Dementia. 2019;15:742\u201353.","journal-title":"Alzheimer's Dementia"},{"key":"324_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-32633-3_3","volume":"1195","author":"CG Lyketsos","year":"2020","unstructured":"Lyketsos CG. Treatment development for Alzheimer\u2019s disease: how are we doing? Adv Exp Med Biol. 2020;1195:19.","journal-title":"Adv Exp Med Biol"},{"key":"324_CR23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s40520-019-01326-z","volume":"32","author":"IA Mavroudis","year":"2020","unstructured":"Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D. A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer\u2019s disease and mild cognitive impairment. Aging Clin Exp Res. 2020;32:1639\u201346.","journal-title":"Aging Clin Exp Res"},{"key":"324_CR24","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, L\u00f3pez-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet. 2020;396:1841\u201356.","journal-title":"Lancet"},{"key":"324_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.trci.2019.02.004","volume":"5","author":"AP Merluzzi","year":"2019","unstructured":"Merluzzi AP, Vogt NM, Norton D, Jonaitis E, Clark LR, Carlsson CM, Johnson SC, Asthana S, Blennow K, Zetterberg H, Bendlin BB. Differential effects of neurodegeneration biomarkers on subclinical cognitive decline. Alzheimer\u2019s Dementia (new York, n.y). 2019;5:129\u201338.","journal-title":"Alzheimer's Dementia (new York, n.y.)"},{"key":"324_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jsr.12474","volume":"26","author":"JRV Molano","year":"2017","unstructured":"Molano JRV, Roe CM, Ju YS. The interaction of sleep and amyloid deposition on cognitive performance. J Sleep Res. 2017;26:288\u201392.","journal-title":"J Sleep Res"},{"key":"324_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/acschemneuro.8b00629","volume":"10","author":"R Naserkhaki","year":"2019","unstructured":"Naserkhaki R, Zamanzadeh S, Baharvand H, Nabavi SM, Pakdaman H, Shahbazi S, Vosough M, Ghaedi G, Barzegar A, Mirtorabi D, Hedayatshodeh M, Ehsani E, Falahati M, Hajipour MJ, Shahpasand K. cis pT231-Tau drives neurodegeneration in bipolar disorder. ACS Chem Neurosci. 2019;10:1214\u201321.","journal-title":"ACS Chem Neurosci"},{"key":"324_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-020-00586-6","volume":"12","author":"P Obrocki","year":"2020","unstructured":"Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, Mattsson N, Andreasson U, Portelius E, Ashton NJ, Blennow K, Scholl M, Paterson RW, Schott JM, Zetterberg H. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course\u2014a joint PhD student course at University College London and University of Gothenburg. Alzheimers Res Ther. 2020;12:20.","journal-title":"Alzheimers Res Ther"},{"key":"324_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jad.2020.05.015","volume":"274","author":"NM Ottesen","year":"2020","unstructured":"Ottesen NM, Meluken I, Frikke-Schmidt R, Plomgaard P, Scheike T, Kessing LV, Miskowiak K, Vinberg M. S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders. J Affect Disord. 2020;274:726\u201332.","journal-title":"J Affect Disord"},{"key":"324_CR30","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/brainsci11101352","volume":"11","author":"G Pandolfo","year":"2021","unstructured":"Pandolfo G, Iannuzzo F, Genovese G, Bruno A, Pioggia G, Baldari S, Gangemi S. Mental illness and amyloid: a scoping review of scientific evidence over the Last 10 Years (2011 to 2021). Brain Sci. 2021;11:1352.","journal-title":"Brain Sci"},{"key":"324_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jad.2020.08.047","volume":"277","author":"J Pech","year":"2020","unstructured":"Pech J, Akh\u00f8j M, Forman J, Kessing LV, Knorr U. The impact of a new affective episode on psychosocial functioning, quality of life and perceived stress in newly diagnosed patients with bipolar disorder: a prospective one-year case\u2013control study. J Affect Disord. 2020;277:486\u201394.","journal-title":"J Affect Disord"},{"key":"324_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/brain\/awaa395","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R, Zetterberg H, Blennow K, Hansson O. Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain. 2021;144:310\u201324.","journal-title":"Brain"},{"key":"324_CR33","volume-title":"Screen for cognitive impairment in psychiatry: administration and psychometric properties","author":"SE Purdon","year":"2005","unstructured":"Purdon SE. Screen for cognitive impairment in psychiatry: administration and psychometric properties. Alberta, Canada: PNL Inc; 2005."},{"key":"324_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17:1016\u201324.","journal-title":"Lancet Neurol"},{"key":"324_CR35","doi-asserted-by":"crossref","unstructured":"Van Rheenen, T.E., Lewandowski, K.E., Bauer, I.E., Kapczinski, F., Miskowiak, K., Burdick, K.E., Balanza-Martinez, V., 2019. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. Bipolar disorders.","DOI":"10.1111\/bdi.12821"},{"key":"324_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jamapsychiatry.2021.4377","volume":"79","author":"LS Richmond-Rakerd","year":"2022","unstructured":"Richmond-Rakerd LS, D\u2019Souza S, Milne BJ, Caspi A, Moffitt TE. Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand Citizens. JAMA Psychiat. 2022;79:333\u201340.","journal-title":"JAMA Psychiat"},{"key":"324_CR37","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1002\/hbm.22788","volume":"36","author":"JR Rieck","year":"2015","unstructured":"Rieck JR, Rodrigue KM, Kennedy KM, Devous MD Sr, Park DC. The effect of beta-amyloid on face processing in young and old adults: a multivariate analysis of the BOLD signal. Hum Brain Mapp. 2015;36:2514\u201326.","journal-title":"Hum Brain Mapp"},{"key":"324_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127100","volume":"10","author":"S Rolstad","year":"2015","unstructured":"Rolstad S, Jakobsson J, Sellgren C, Ekman CJ, Blennow K, Zetterberg H, Palsson E, Landen M. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls. PLoS ONE. 2015;10: e0127100.","journal-title":"PLoS ONE"},{"key":"324_CR39","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1017\/S003329171700143X","volume":"47","author":"M Russo","year":"2017","unstructured":"Russo M, Van Rheenen TE, Shanahan M, Mahon K, Perez-Rodriguez MM, Cuesta-Diaz A, Larsen E, Malhotra AK, Burdick KE. Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings. Psychol Med. 2017;47:2892\u2013905.","journal-title":"Psychol Med"},{"key":"324_CR40","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1111\/ejn.15656","volume":"56","author":"TS Saunders","year":"2022","unstructured":"Saunders TS, Gadd DA, Spires-Jones TL, King D, Ritchie C, Muniz-Terrera G. Associations between cerebrospinal fluid markers and cognition in ageing and dementia: a systematic review. Eur J Neurosci. 2022;56:5650\u2013713.","journal-title":"Eur J Neurosci"},{"key":"324_CR41","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.66","volume":"7","author":"T Sparding","year":"2021","unstructured":"Sparding T, Joas E, Clements C, Sellgren CM, P\u00e5lsson E, Land\u00e9n M. Long-term trajectory of cognitive performance in people with bipolar disorder and controls: 6-year longitudinal study. Bjpsych Open. 2021;7: e115.","journal-title":"Bjpsych Open"},{"key":"324_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bdi.12841","volume":"22","author":"A Szmulewicz","year":"2019","unstructured":"Szmulewicz A, Valerio MP, Martino DJ. Longitudinal analysis of cognitive performances in recent-onset and late-life bipolar disorder: a systematic review and meta-analysis. Bipolar Disord. 2019;22:28\u201337.","journal-title":"Bipolar Disord"},{"key":"324_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/acps.13153","volume":"141","author":"J Velosa","year":"2020","unstructured":"Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand. 2020;141:510\u201321.","journal-title":"Acta Psychiatr Scand"},{"key":"324_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","volume":"47","author":"JK Wing","year":"1990","unstructured":"Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47:589\u201393.","journal-title":"Arch Gen Psychiatry"},{"key":"324_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00213-016-4473-9","volume":"234","author":"M Xia","year":"2017","unstructured":"Xia M, Yang L, Sun G, Qi S, Li B. Mechanism of depression as a risk factor in the development of Alzheimer\u2019s disease: the function of AQP4 and the glymphatic system. Psychopharmacology. 2017;234:365\u201379.","journal-title":"Psychopharmacology"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-023-00324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-023-00324-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-023-00324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T16:05:57Z","timestamp":1705421157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-023-00324-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1186\/s40345-023-00324-5","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Local Ethical Committee (H-6-2014-006) and the Danish Data Protection Agency, Capital Region of Copenhagen. The study complied with the latest Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors UK, AHS, MW, JF, and SGH declare no conflicts of interest. HZ has served on scientific advisory boards and\/or as a consultant for Abbvie, Alector, Annexon, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, and Biogen. KB has served as a consultant or on advisory boards for Alzheon, BioArtic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Merck, Pfizer, and Roche Diagnostics. HZ and KB are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. KWM reports having received consultancy fees from Lundbeck and Janssen in the past 3\u00a0years. LVK has within the preceding 3 years been a consultant for Lundbeck and Teva.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}